233 related articles for article (PubMed ID: 7114635)
1. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Watanakunakorn C
Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635
[TBL] [Abstract][Full Text] [Related]
2. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Waldvogel FA
J Hosp Infect; 1986 Mar; 7 Suppl A():37-46. PubMed ID: 2871096
[No Abstract] [Full Text] [Related]
3. The emergence of methicillin-resistant Staphylococcus aureus.
Wenzel RP
Ann Intern Med; 1982 Sep; 97(3):440-2. PubMed ID: 7114639
[No Abstract] [Full Text] [Related]
4. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Bayer AS; Morrison JO
Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
[TBL] [Abstract][Full Text] [Related]
5. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
Sorrell TC; Packham DR; Shanker S; Foldes M; Munro R
Ann Intern Med; 1982 Sep; 97(3):344-50. PubMed ID: 7114631
[TBL] [Abstract][Full Text] [Related]
7. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Harvey K; Pavillard R
Med J Aust; 1982 May; 1(11):465-7. PubMed ID: 7048040
[TBL] [Abstract][Full Text] [Related]
8. Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection.
Eng RH; Smith SM; Tillem M; Cherubin C
Arch Intern Med; 1985 Jan; 145(1):146-8. PubMed ID: 3844314
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
Bayer AS; Lam K
J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
[TBL] [Abstract][Full Text] [Related]
10. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Klastersky J; Van der Auwera P
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
[TBL] [Abstract][Full Text] [Related]
12. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Chambers HF
Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
[TBL] [Abstract][Full Text] [Related]
14. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
Burnie J; Matthews R; Jiman-Fatami A; Gottardello P; Hodgetts S; D'arcy S
Clin Infect Dis; 2000 Sep; 31(3):684-9. PubMed ID: 11017816
[TBL] [Abstract][Full Text] [Related]
15. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
16. Interaction between vancomycin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Guerriero JC
Antimicrob Agents Chemother; 1981 Jun; 19(6):1089-91. PubMed ID: 7271276
[TBL] [Abstract][Full Text] [Related]
17. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
[TBL] [Abstract][Full Text] [Related]
18. New trends in the chemotherapy of staphylococcal infections.
Russo G; Tempera G; Stefani S; Nicoletti G
Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
[TBL] [Abstract][Full Text] [Related]
19. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981.
Markowitz N; Pohlod DJ; Saravolatz LD; Quinn EL
Antimicrob Agents Chemother; 1983 Mar; 23(3):450-7. PubMed ID: 6552151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
